Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination [NA]
Completed clinical trial evaluating a message framing intervention to increase parental acceptance of HPV vaccination.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa" [Phase 3]
Phase 3 clinical trial update for a study evaluating HPV testing-based algorithms for cervical cancer screening and treatment in Africa.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) [Phase 1]
Phase 1 trial update of bintrafusp alfa in combination therapy for cervical cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Treated for Cervical Cancer (PROVIDENCE) [Phase 4]
Phase 4 clinical trial evaluating a multimodal intervention to improve sexual health and quality of life in patients treated for cervical ca…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations [Phase 2]
A Phase 2 clinical trial update shows results for trastuzumab deruxtecan (Enhertu) in solid tumors with HER2 activating mutations; the study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer [Phase 3]
Phase 3 trial update evaluating a triple antiemetic regimen for chemoradiotherapy in cervical cancer or nasopharyngeal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer [Phase 3]
A Phase 3 trial comparing neoadjuvant chemotherapy to definite concurrent chemoradiotherapy for locally advanced bulky cervical cancer is on…
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma [Phase 2]
Phase Ⅱ study of F520 in cervical cancer has completed, reporting early results from a Phase 2 trial.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for HB0028 in advanced solid tumors and cervical cancer across Phase 1/Phase 2; no results data provided.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating toripalimab with concurrent chemoradiotherapy for cervical cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer [Phase 2, Phase 3]
Clinical trial update for QL1604 plus chemotherapy in advanced cervical cancer; study has terminated.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of a vaccination targeting HPV16-related cancers in head and neck, cervical, and anal cancers…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers [Phase 3]
Phase 3 trial evaluating the addition of Triapine to cisplatin-based chemoradiation for cervical and vaginal cancers; results were posted in…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers [Phase 3]
Phase 3 trial update evaluating adding Triapine to cisplatin-based chemoradiation for advanced cervical and vaginal cancers is in active not…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer [Phase 3]
A Phase 3 trial evaluating induction chemotherapy with immunotherapy followed by concurrent chemoradiation in advanced cervical cancer is cu…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy [Phase 2]
Phase II clinical study evaluating IBI310 or placebo with sintilimab for advanced cervical cancer after failure or intolerance to platinum-b…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer [Phase 2]
Phase 2 trial updates the combination of VB10.16 (Nykode) and atezolizumab in HPV-16 positive cervical cancer; study status is completed.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 9-valent HPV recombinant vaccine in Chinese healthy females has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for a combination immunotherapy regimen in adults with advanced HPV-associated cancers.…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial evaluating adding cetuximab to chemotherapy for advanced or recurrent cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) [Phase 3]
Phase 3 trial KEYNOTE-826 evaluating pembrolizumab plus chemotherapy vs placebo plus chemotherapy in first-line cervical cancer; results dem…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Rural Interventions for Screening Effectiveness [NA]
Completed clinical trial evaluating rural interventions to improve screening effectiveness for breast, cervical, or colorectal cancer; resul…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread [Phase 3]
A Phase 3 trial evaluating induction chemotherapy followed by standard therapy for cervical cancer with aortic lymph node involvement is cur…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy [Phase 3]
Phase 3 trial investigating radical surgery with or without adjuvant radiotherapy for intermediate-risk cervical cancer is currently recruit…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer [Phase 2]
Phase 2 trial update evaluating PEG-rhG-CSF to prevent neutropenia during concurrent chemoradiotherapy for cervical cancer.